Methods
Point-prevalence surveys were conducted at seven hospitals (adult,
pediatric, government and private-funded, district- and tertiary-level)
in Cape Town, South Africa between April 2019 and June 2021. Ward
prescription records and interviews were conducted to identify BLA
patients. De-labeling was attempted at the tertiary allergy clinic at
Groote Schuur hospital.